ConductScience.org, home

Comparison · NCT00201643-edfa41b1

Rescue Course of Betamethasone or Dexamethasone vs Placebo (Normal Saline): Maternal Infectious Morbidity.

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

2 sourcestrial-comparisons-2026-03-23-0.1.0

Download JSON
Cite this record

ConductScience Library. Rescue Course of Betamethasone or Dexamethasone vs Placebo (Normal Saline): Maternal Infectious Morbidity. Trial comparisons, record NCT00201643-edfa41b1. Release trial-comparisons-2026-03-23-0.1.0, 23 Mar 2026. https://conductscience.org/library/comparisons/NCT00201643-edfa41b1

On this page

Measures6

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

MeasureValue95% interval, lower95% interval, upperMethodNote
Risk in group 10.03590.01830.0692wilson
Risk in group 20.04670.02560.0839wilson
Risk difference, group 1 minus group 2-0.0109-0.05190.0286newcombe hybrid score
Risk ratio, group 1 over group 20.7680.3091.91log
Odds ratio, group 1 over group 20.7590.2941.96log
Number needed to treat, for one fewer participant with the outcome on Rescue Course of Betamethasone or Dexamethasone than on Placebo (Normal Saline)92.1from the risk difference intervalthe interval includes no difference

Groups2

Group 2 names the comparator: placebo.

GroupTitleDescriptionWith the outcomeAnalysedClinicalTrials.gov code
Group 1Rescue Course of Betamethasone or Dexamethasone
Receive 2nd Rescue Course = Study drug (betamethasone or dexamethasone. If Dexamethasone, administered 6 mg IM q 12 hours x 4 doses total. If Betamethasone was used, 2 doses of 12 mg of betamethasone was given intramuscularly (IM) 24 hours apart.
8223OG000
Group 2Placebo (Normal Saline)
Placebo consisted of quantity sufficient of Normal Saline with preservatives, Benzylalcohol and Benzylbenzoate.~The research subject received 2 doses of pharmacy prepared placebo (2ml normal saline)to conceal administration of dexamethasone or if to conceal betamethasone, 2 doses of Placebo (2ml normal saline) given IM 24 hours apart.
10214OG001

Outcome

Type
SECONDARY
Title
Maternal Infectious Morbidity.
Description
Total number of Mothers having Maternal infectious morbidity (e.g. endometritis \& maternal sepsis) noted from birth through 28 days after birth
Time frame
Up to 28 days after giving birth
Population
ITT

Source ClinicalTrials.gov

Trial

Title
A Randomized Trial Comparing the Impact of One Versus Two Courses of Antenatal Steroids (ACS) on Neonatal Outcome
NCT number
NCT00201643
Phases
PHASE4
Conditions
Preterm Delivery
Interventions
Betamethasone or Dexamethasone (2nd course of ACS), Placebo
Lead sponsor
Obstetrix Medical Group
Results first posted
2011-03-01

Source ClinicalTrials.gov

Source

Release
trial-comparisons-2026-03-23-0.1.0
Release manifest SHA-256
f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57
AACT copy
2026-03-23
Tables read
outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet

Source ClinicalTrials.gov

Sources 2

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.

For software

Read this comparison from software.

The record is JSON. No key.

GET https://conductscience.org/api/comparisons/v1/NCT00201643-edfa41b1